T Cell Transfer Therapy Market - Global Outlook and Forecast 2022-2028

March 2022 | 69 pages | ID: TFD99DDF1F78EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of T Cell Transfer Therapy in Global, including the following market information:

Global T Cell Transfer Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global T Cell Transfer Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Autologous Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of T Cell Transfer Therapy include Roche, Merck, Novartis, Johnson & Johnson, Glaxosmithkline, Amgen, Abbvie, Astrazeneca and Bristol-Myers Squibb and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the T Cell Transfer Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global T Cell Transfer Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global T Cell Transfer Therapy Market Segment Percentages, by Type, 2021 (%)

• Autologous
• Allogeneic

Global T Cell Transfer Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global T Cell Transfer Therapy Market Segment Percentages, by Application, 2021 (%)

• Child
• Adult
• The Elderly

Global T Cell Transfer Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global T Cell Transfer Therapy Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies T Cell Transfer Therapy revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies T Cell Transfer Therapy revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Roche
• Merck
• Novartis
• Johnson & Johnson
• Glaxosmithkline
• Amgen
• Abbvie
• Astrazeneca
• Bristol-Myers Squibb
• ELI Lilly

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 T Cell Transfer Therapy Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global T Cell Transfer Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL T CELL TRANSFER THERAPY OVERALL MARKET SIZE

2.1 Global T Cell Transfer Therapy Market Size: 2021 VS 2028
2.2 Global T Cell Transfer Therapy Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top T Cell Transfer Therapy Players in Global Market
3.2 Top Global T Cell Transfer Therapy Companies Ranked by Revenue
3.3 Global T Cell Transfer Therapy Revenue by Companies
3.4 Top 3 and Top 5 T Cell Transfer Therapy Companies in Global Market, by Revenue in 2021
3.5 Global Companies T Cell Transfer Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 T Cell Transfer Therapy Players in Global Market
  3.6.1 List of Global Tier 1 T Cell Transfer Therapy Companies
  3.6.2 List of Global Tier 2 and Tier 3 T Cell Transfer Therapy Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global T Cell Transfer Therapy Market Size Markets, 2021 & 2028
  4.1.2 Autologous
  4.1.3 Allogeneic
4.2 By Type - Global T Cell Transfer Therapy Revenue & Forecasts
  4.2.1 By Type - Global T Cell Transfer Therapy Revenue, 2017-2022
  4.2.2 By Type - Global T Cell Transfer Therapy Revenue, 2023-2028
  4.2.3 By Type - Global T Cell Transfer Therapy Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global T Cell Transfer Therapy Market Size, 2021 & 2028
  5.1.2 Child
  5.1.3 Adult
  5.1.4 The Elderly
5.2 By Application - Global T Cell Transfer Therapy Revenue & Forecasts
  5.2.1 By Application - Global T Cell Transfer Therapy Revenue, 2017-2022
  5.2.2 By Application - Global T Cell Transfer Therapy Revenue, 2023-2028
  5.2.3 By Application - Global T Cell Transfer Therapy Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global T Cell Transfer Therapy Market Size, 2021 & 2028
6.2 By Region - Global T Cell Transfer Therapy Revenue & Forecasts
  6.2.1 By Region - Global T Cell Transfer Therapy Revenue, 2017-2022
  6.2.2 By Region - Global T Cell Transfer Therapy Revenue, 2023-2028
  6.2.3 By Region - Global T Cell Transfer Therapy Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America T Cell Transfer Therapy Revenue, 2017-2028
  6.3.2 US T Cell Transfer Therapy Market Size, 2017-2028
  6.3.3 Canada T Cell Transfer Therapy Market Size, 2017-2028
  6.3.4 Mexico T Cell Transfer Therapy Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe T Cell Transfer Therapy Revenue, 2017-2028
  6.4.2 Germany T Cell Transfer Therapy Market Size, 2017-2028
  6.4.3 France T Cell Transfer Therapy Market Size, 2017-2028
  6.4.4 U.K. T Cell Transfer Therapy Market Size, 2017-2028
  6.4.5 Italy T Cell Transfer Therapy Market Size, 2017-2028
  6.4.6 Russia T Cell Transfer Therapy Market Size, 2017-2028
  6.4.7 Nordic Countries T Cell Transfer Therapy Market Size, 2017-2028
  6.4.8 Benelux T Cell Transfer Therapy Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia T Cell Transfer Therapy Revenue, 2017-2028
  6.5.2 China T Cell Transfer Therapy Market Size, 2017-2028
  6.5.3 Japan T Cell Transfer Therapy Market Size, 2017-2028
  6.5.4 South Korea T Cell Transfer Therapy Market Size, 2017-2028
  6.5.5 Southeast Asia T Cell Transfer Therapy Market Size, 2017-2028
  6.5.6 India T Cell Transfer Therapy Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America T Cell Transfer Therapy Revenue, 2017-2028
  6.6.2 Brazil T Cell Transfer Therapy Market Size, 2017-2028
  6.6.3 Argentina T Cell Transfer Therapy Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa T Cell Transfer Therapy Revenue, 2017-2028
  6.7.2 Turkey T Cell Transfer Therapy Market Size, 2017-2028
  6.7.3 Israel T Cell Transfer Therapy Market Size, 2017-2028
  6.7.4 Saudi Arabia T Cell Transfer Therapy Market Size, 2017-2028
  6.7.5 UAE T Cell Transfer Therapy Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Roche
  7.1.1 Roche Corporate Summary
  7.1.2 Roche Business Overview
  7.1.3 Roche T Cell Transfer Therapy Major Product Offerings
  7.1.4 Roche T Cell Transfer Therapy Revenue in Global Market (2017-2022)
  7.1.5 Roche Key News
7.2 Merck
  7.2.1 Merck Corporate Summary
  7.2.2 Merck Business Overview
  7.2.3 Merck T Cell Transfer Therapy Major Product Offerings
  7.2.4 Merck T Cell Transfer Therapy Revenue in Global Market (2017-2022)
  7.2.5 Merck Key News
7.3 Novartis
  7.3.1 Novartis Corporate Summary
  7.3.2 Novartis Business Overview
  7.3.3 Novartis T Cell Transfer Therapy Major Product Offerings
  7.3.4 Novartis T Cell Transfer Therapy Revenue in Global Market (2017-2022)
  7.3.5 Novartis Key News
7.4 Johnson & Johnson
  7.4.1 Johnson & Johnson Corporate Summary
  7.4.2 Johnson & Johnson Business Overview
  7.4.3 Johnson & Johnson T Cell Transfer Therapy Major Product Offerings
  7.4.4 Johnson & Johnson T Cell Transfer Therapy Revenue in Global Market (2017-2022)
  7.4.5 Johnson & Johnson Key News
7.5 Glaxosmithkline
  7.5.1 Glaxosmithkline Corporate Summary
  7.5.2 Glaxosmithkline Business Overview
  7.5.3 Glaxosmithkline T Cell Transfer Therapy Major Product Offerings
  7.5.4 Glaxosmithkline T Cell Transfer Therapy Revenue in Global Market (2017-2022)
  7.5.5 Glaxosmithkline Key News
7.6 Amgen
  7.6.1 Amgen Corporate Summary
  7.6.2 Amgen Business Overview
  7.6.3 Amgen T Cell Transfer Therapy Major Product Offerings
  7.6.4 Amgen T Cell Transfer Therapy Revenue in Global Market (2017-2022)
  7.6.5 Amgen Key News
7.7 Abbvie
  7.7.1 Abbvie Corporate Summary
  7.7.2 Abbvie Business Overview
  7.7.3 Abbvie T Cell Transfer Therapy Major Product Offerings
  7.7.4 Abbvie T Cell Transfer Therapy Revenue in Global Market (2017-2022)
  7.7.5 Abbvie Key News
7.8 Astrazeneca
  7.8.1 Astrazeneca Corporate Summary
  7.8.2 Astrazeneca Business Overview
  7.8.3 Astrazeneca T Cell Transfer Therapy Major Product Offerings
  7.8.4 Astrazeneca T Cell Transfer Therapy Revenue in Global Market (2017-2022)
  7.8.5 Astrazeneca Key News
7.9 Bristol-Myers Squibb
  7.9.1 Bristol-Myers Squibb Corporate Summary
  7.9.2 Bristol-Myers Squibb Business Overview
  7.9.3 Bristol-Myers Squibb T Cell Transfer Therapy Major Product Offerings
  7.9.4 Bristol-Myers Squibb T Cell Transfer Therapy Revenue in Global Market (2017-2022)
  7.9.5 Bristol-Myers Squibb Key News
7.10 ELI Lilly
  7.10.1 ELI Lilly Corporate Summary
  7.10.2 ELI Lilly Business Overview
  7.10.3 ELI Lilly T Cell Transfer Therapy Major Product Offerings
  7.10.4 ELI Lilly T Cell Transfer Therapy Revenue in Global Market (2017-2022)
  7.10.5 ELI Lilly Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. T Cell Transfer Therapy Market Opportunities & Trends in Global Market
Table 2. T Cell Transfer Therapy Market Drivers in Global Market
Table 3. T Cell Transfer Therapy Market Restraints in Global Market
Table 4. Key Players of T Cell Transfer Therapy in Global Market
Table 5. Top T Cell Transfer Therapy Players in Global Market, Ranking by Revenue (2021)
Table 6. Global T Cell Transfer Therapy Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global T Cell Transfer Therapy Revenue Share by Companies, 2017-2022
Table 8. Global Companies T Cell Transfer Therapy Product Type
Table 9. List of Global Tier 1 T Cell Transfer Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 T Cell Transfer Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global T Cell Transfer Therapy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - T Cell Transfer Therapy Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - T Cell Transfer Therapy Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global T Cell Transfer Therapy Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - T Cell Transfer Therapy Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - T Cell Transfer Therapy Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global T Cell Transfer Therapy Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global T Cell Transfer Therapy Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global T Cell Transfer Therapy Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America T Cell Transfer Therapy Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America T Cell Transfer Therapy Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe T Cell Transfer Therapy Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe T Cell Transfer Therapy Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia T Cell Transfer Therapy Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia T Cell Transfer Therapy Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America T Cell Transfer Therapy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America T Cell Transfer Therapy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa T Cell Transfer Therapy Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa T Cell Transfer Therapy Revenue, (US$, Mn), 2023-2028
Table 30. Roche Corporate Summary
Table 31. Roche T Cell Transfer Therapy Product Offerings
Table 32. Roche T Cell Transfer Therapy Revenue (US$, Mn), (2017-2022)
Table 33. Merck Corporate Summary
Table 34. Merck T Cell Transfer Therapy Product Offerings
Table 35. Merck T Cell Transfer Therapy Revenue (US$, Mn), (2017-2022)
Table 36. Novartis Corporate Summary
Table 37. Novartis T Cell Transfer Therapy Product Offerings
Table 38. Novartis T Cell Transfer Therapy Revenue (US$, Mn), (2017-2022)
Table 39. Johnson & Johnson Corporate Summary
Table 40. Johnson & Johnson T Cell Transfer Therapy Product Offerings
Table 41. Johnson & Johnson T Cell Transfer Therapy Revenue (US$, Mn), (2017-2022)
Table 42. Glaxosmithkline Corporate Summary
Table 43. Glaxosmithkline T Cell Transfer Therapy Product Offerings
Table 44. Glaxosmithkline T Cell Transfer Therapy Revenue (US$, Mn), (2017-2022)
Table 45. Amgen Corporate Summary
Table 46. Amgen T Cell Transfer Therapy Product Offerings
Table 47. Amgen T Cell Transfer Therapy Revenue (US$, Mn), (2017-2022)
Table 48. Abbvie Corporate Summary
Table 49. Abbvie T Cell Transfer Therapy Product Offerings
Table 50. Abbvie T Cell Transfer Therapy Revenue (US$, Mn), (2017-2022)
Table 51. Astrazeneca Corporate Summary
Table 52. Astrazeneca T Cell Transfer Therapy Product Offerings
Table 53. Astrazeneca T Cell Transfer Therapy Revenue (US$, Mn), (2017-2022)
Table 54. Bristol-Myers Squibb Corporate Summary
Table 55. Bristol-Myers Squibb T Cell Transfer Therapy Product Offerings
Table 56. Bristol-Myers Squibb T Cell Transfer Therapy Revenue (US$, Mn), (2017-2022)
Table 57. ELI Lilly Corporate Summary
Table 58. ELI Lilly T Cell Transfer Therapy Product Offerings
Table 59. ELI Lilly T Cell Transfer Therapy Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. T Cell Transfer Therapy Segment by Type in 2021
Figure 2. T Cell Transfer Therapy Segment by Application in 2021
Figure 3. Global T Cell Transfer Therapy Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global T Cell Transfer Therapy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global T Cell Transfer Therapy Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by T Cell Transfer Therapy Revenue in 2021
Figure 8. By Type - Global T Cell Transfer Therapy Revenue Market Share, 2017-2028
Figure 9. By Application - Global T Cell Transfer Therapy Revenue Market Share, 2017-2028
Figure 10. By Region - Global T Cell Transfer Therapy Revenue Market Share, 2017-2028
Figure 11. By Country - North America T Cell Transfer Therapy Revenue Market Share, 2017-2028
Figure 12. US T Cell Transfer Therapy Revenue, (US$, Mn), 2017-2028
Figure 13. Canada T Cell Transfer Therapy Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico T Cell Transfer Therapy Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe T Cell Transfer Therapy Revenue Market Share, 2017-2028
Figure 16. Germany T Cell Transfer Therapy Revenue, (US$, Mn), 2017-2028
Figure 17. France T Cell Transfer Therapy Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. T Cell Transfer Therapy Revenue, (US$, Mn), 2017-2028
Figure 19. Italy T Cell Transfer Therapy Revenue, (US$, Mn), 2017-2028
Figure 20. Russia T Cell Transfer Therapy Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries T Cell Transfer Therapy Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux T Cell Transfer Therapy Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia T Cell Transfer Therapy Revenue Market Share, 2017-2028
Figure 24. China T Cell Transfer Therapy Revenue, (US$, Mn), 2017-2028
Figure 25. Japan T Cell Transfer Therapy Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea T Cell Transfer Therapy Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia T Cell Transfer Therapy Revenue, (US$, Mn), 2017-2028
Figure 28. India T Cell Transfer Therapy Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America T Cell Transfer Therapy Revenue Market Share, 2017-2028
Figure 30. Brazil T Cell Transfer Therapy Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina T Cell Transfer Therapy Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa T Cell Transfer Therapy Revenue Market Share, 2017-2028
Figure 33. Turkey T Cell Transfer Therapy Revenue, (US$, Mn), 2017-2028
Figure 34. Israel T Cell Transfer Therapy Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia T Cell Transfer Therapy Revenue, (US$, Mn), 2017-2028
Figure 36. UAE T Cell Transfer Therapy Revenue, (US$, Mn), 2017-2028
Figure 37. Roche T Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Merck T Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novartis T Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Johnson & Johnson T Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Glaxosmithkline T Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Amgen T Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Abbvie T Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Astrazeneca T Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Bristol-Myers Squibb T Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. ELI Lilly T Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)